Spectrum Pharmaceuticals Valuation
SPPIDelisted Stock | USD 1.03 0.00 0.00% |
Today, the company appears to be overvalued. Spectrum Pharmaceuticals has a current Real Value of $0.92 per share. The regular price of the company is $1.03. Our model measures the value of Spectrum Pharmaceuticals from inspecting the company fundamentals such as Shares Outstanding of 205.25 M, operating margin of (2.47) %, and Return On Equity of -1.65 as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend purchasing undervalued stocks and trading away overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Overvalued
Today
Please note that Spectrum Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Spectrum Pharmaceuticals is based on 3 months time horizon. Increasing Spectrum Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Spectrum Pharmaceuticals is useful when determining the fair value of the Spectrum stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Spectrum Pharmaceuticals. Since Spectrum Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Spectrum Stock. However, Spectrum Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 1.03 | Real 0.92 | Hype 1.03 |
The real value of Spectrum Stock, also known as its intrinsic value, is the underlying worth of Spectrum Pharmaceuticals Company, which is reflected in its stock price. It is based on Spectrum Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Spectrum Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Spectrum Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Spectrum Pharmaceuticals helps investors to forecast how Spectrum stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Spectrum Pharmaceuticals more accurately as focusing exclusively on Spectrum Pharmaceuticals' fundamentals will not take into account other important factors: Spectrum Pharmaceuticals Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Spectrum Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Spectrum Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Spectrum Pharmaceuticals competition to find correlations between indicators driving Spectrum Pharmaceuticals's intrinsic value. More Info.Spectrum Pharmaceuticals is rated below average in price to earning category among related companies. It is rated below average in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Spectrum Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Spectrum Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Spectrum Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Spectrum Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Spectrum Pharmaceuticals and how it compares across the competition.
About Spectrum Pharmaceuticals Valuation
The delisted stock valuation mechanism determines the current worth of Spectrum Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Spectrum Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Spectrum Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Spectrum Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Spectrum Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Spectrum Pharmaceuticals. We calculate exposure to Spectrum Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Spectrum Pharmaceuticals's related companies.Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is based in Boston, Massachusetts. Spectrum Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 163 people.
8 Steps to conduct Spectrum Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Spectrum Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Spectrum Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Spectrum Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Spectrum Pharmaceuticals' revenue streams: Identify Spectrum Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Spectrum Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Spectrum Pharmaceuticals' growth potential: Evaluate Spectrum Pharmaceuticals' management, business model, and growth potential.
- Determine Spectrum Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Spectrum Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Spectrum Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Spectrum Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding | 183.2 M | |
Forward Price Earnings | 4.7483 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Spectrum Stock
If you are still planning to invest in Spectrum Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Spectrum Pharmaceuticals' history and understand the potential risks before investing.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Stocks Directory Find actively traded stocks across global markets |